plumbagin has been researched along with Tongue Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Q; Liu, C; Qiu, J; Xin, Y | 1 |
| Qiu, J; Xue, D; Zhou, X | 1 |
| Huang, D; Na, S; Qiu, J; Tang, A; Xu, Q; Xue, D; Zhang, J; Zhou, X | 1 |
| He, YQ; Mao, ZF; Qin, Y; Qiu, JX; Shen, X; Wang, Y; Xu, RL; Zhou, SF | 1 |
| He, ZX; Pan, ST; Qin, Y; Qiu, JX; Wang, D; Yang, T; Yang, YX; Zhang, X; Zhou, SF; Zhou, ZW | 2 |
6 other study(ies) available for plumbagin and Tongue Neoplasms
| Article | Year |
|---|---|
Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Head and Neck Neoplasms; Humans; Mice; Tongue Neoplasms; Transcription Factors; Tumor Microenvironment | 2023 |
Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Male; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Phytotherapy; Plant Extracts; Tongue; Tongue Neoplasms; TOR Serine-Threonine Kinases | 2021 |
Plumbagin-mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Female; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Male; Matrix Metalloproteinase 2; Mice; Middle Aged; Naphthoquinones; Platelet Endothelial Cell Adhesion Molecule-1; Tongue Neoplasms; Tumor Stem Cell Assay | 2018 |
Plumbagin induces the apoptosis of human tongue carcinoma cells through the mitochondria-mediated pathway.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Deoxyuridine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Humans; Mitochondria; Mitosis; Naphthoquinones; Signal Transduction; Time Factors; Tongue Neoplasms; Tumor Stem Cell Assay | 2013 |
Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Topics: Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Division; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; MAP Kinase Signaling System; Molecular Structure; Naphthoquinones; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship; Tongue Neoplasms; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2015 |
Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; G2 Phase Cell Cycle Checkpoints; Head and Neck Neoplasms; Humans; Naphthoquinones; Neoplastic Stem Cells; NF-E2-Related Factor 2; Oxidative Stress; Protein Interaction Maps; Protein Transport; Proteomics; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tongue Neoplasms | 2015 |